Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Public Statement onSifrol, Daquiran, Mirapexin (Pramipexole) - Sudden onset of sleep 19 July 1999News Committee for veterinary medicinal products: 45th meeting 15 July 1999Press releaseVeterinary Committee for Proprietary Medicinal Products (CPMP) 50th plenary meeting 25 June 1999Press release Committee for veterinary medicinal products: 44th meeting 18 June 1999Press releaseVeterinary Public Statement on Trovan / Trovan IV / Turvel / Turvel IV (Trovafloxacin/Alatrofloxacin) recommendation to suspend the marketing authorisation in the European Union 15 June 1999News Twenty-second Meeting of the Management Board 3 June 1999Press releaseCorporate Meeting of the EMEA working party on herbal medicinal products 31 May - 1 June 1999 3 June 1999NewsHerbal Committee for Proprietary Medicinal Products (CPMP) 49th plenary meeting 25 May 1999Press release Public Statement on Trovan/Trovan IV/Turvel/Turvel IV (Trovafloxacin/Alatrofloxacin): Serious, severe and unpredictable liver injuries 25 May 1999News Committee for Proprietary Medicinal Products (CPMP) 48th plenary meeting 26 April 1999Press release 1 … 369 370 371 372 373 Page 373 of 384 374 375 376 377 … 384
Public Statement onSifrol, Daquiran, Mirapexin (Pramipexole) - Sudden onset of sleep 19 July 1999News
Public Statement on Trovan / Trovan IV / Turvel / Turvel IV (Trovafloxacin/Alatrofloxacin) recommendation to suspend the marketing authorisation in the European Union 15 June 1999News
Meeting of the EMEA working party on herbal medicinal products 31 May - 1 June 1999 3 June 1999NewsHerbal
Public Statement on Trovan/Trovan IV/Turvel/Turvel IV (Trovafloxacin/Alatrofloxacin): Serious, severe and unpredictable liver injuries 25 May 1999News
